epidemiology and diagnosis a practical guide to therapy monotherapy combination therapy add ons
TRANSCRIPT
Epidemiology and Diagnosis
A Practical Guide to Therapy
Monotherapy
Combination Therapy
Add ons
Impaired GlucoseTolerance - IGT
Impaired FastingGlucose - IFG
Beta cell mechanism
Insulin secretion and Glucose regulation
Effects of hyper glycemia
Biphasic Insulin response
Insulin secretagogues
Glycaemic goals & Pregnancy
Diabetic retinopathy
Glitazones
Hyperglycemia
Etiologic classification of diabetes mellitus
Glucose tolerance categories
Diagnosis of Diabetes
Diagnosis of Diabetes II
Management Goals
Metabolic Targets
Deterioration in Median
Antihyperglycemic Agents
Antihyperglycemic Agents(Sites)
Antihyperglycemic Agents(Mechanism)
The -Glucosidase inhibitors
The -Glucosidase inhibitors(Effect)
Acarbose Effect on HbA1c
The Biguanides(Characteristics)
Metformin (Mechanism)
Metformin Effect(Glucose)
Metformin Effect(HbA1c)
Dose Response(Metformin)
Insulin Secretagogues
Repaglinide Effect(HbA1c)
Repaglinide after Sulfonylurea
Sulfonylurea Effect(Glucose)
Dose Response(Sulfonylurea)
Once vs Twice daily(Sulfonylurea)
Placebo subtracted dose
Selected insulin secretagogues
-Glucosidase Dosing
Hypoglycemic episodes
Sulfonylureas
Insulin Secretagogues
Initial treatment
Secondary Failures
Metformin
-Glucosidase Inhibitors
Glycemic Improvements
Sulfonylurea+Metformin
Sulfonylurea+Acarbose
Combinations of Oral agents
Secondary Failure
Metformin+Repaglinide
Metformin+Acarbose
Glimepride+Insulin(FPG)
Glimepride+Insulin(HbA1c)
Oral Agents+Insulin
Sulfonyurea+Insulin
Insulin+Metformin(HbA1c)
Insulin+Metformin(Effect)